Natural killer cell-directed therapies: moving from unexpected results to successful strategies.
about
Signaling in Effector Lymphocytes: Insights toward Safer ImmunotherapyNatural Killer Cells and Liver FibrosisAlloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive ImmunotherapyCritical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic StressWays to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytesA new adenovirus based vaccine vector expressing an Eimeria tenella derived TLR agonist improves cellular immune responses to an antigenic targetUnderstanding of molecular mechanisms in natural killer cell therapyCEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signalingEnhanced antitumor immunity contributes to the radio-sensitization of ehrlich ascites tumor by the glycolytic inhibitor 2-deoxy-D-glucose in miceInnate or adaptive immunity? The example of natural killer cellsEarly NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis.EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells.Immunological tolerance and tumor rejection in embryo-aggregated chimeric mice - lessons for tumor immunity.Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha.Immune-based therapeutics for pediatric cancer.Efficacy of ex vivo activated and expanded natural killer cells and T lymphocytes for colorectal cancer patients.NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection.A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against RhabdomyosarcomaTreatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancerNK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DCRole of the innate immune response and tumor immunity associated with simian virus 40 large tumor antigen.Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspectiveLiver myofibroblasts from hepatitis B related liver failure patients may regulate natural killer cell function via PGE2.GMP-compliant, large-scale expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells in vitro and in vivo.Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells.NK cell-based immunotherapy for treating cancer: will it be promising?Gene expression analysis of ex vivo expanded and freshly isolated NK cells from cancer patients.Natural killer cell-based therapies.The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development.Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides.MHC-I modulation due to changes in tumor cell metabolism regulates tumor sensitivity to CTL and NK cells.IFNα signaling through PKC-θ is essential for antitumor NK cell functionEradicating HIV-1 infection: seeking to clear a persistent pathogen.Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression.Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity.NK cells: immune cross-talk and therapeutic implications.NK cell-based immunotherapies in Pediatric Oncology.Present and Future of Allogeneic Natural Killer Cell TherapyPotential Therapeutic Effect of Natural Killer Cells on Doxorubicin-Resistant Breast Cancer Cells In Vitro.
P2860
Q26744654-F0061758-5AC8-4A64-823C-E5B489356B2DQ26767448-8C0A4359-63EF-443C-B306-F953C0CE9343Q26777209-3C4C995D-F7D8-4D42-95C4-2F2145377DF7Q26781260-4477654B-2D7A-4245-AE8F-241D1982AB71Q26991991-1EC433A3-555C-4CF9-B55E-73DF722E3EA4Q27333475-DC91D05F-57EF-43E8-8D2D-8EF2D2DC52FCQ28086976-B007CAEB-6286-43E5-968A-310A47F88DF4Q28115742-64B5897C-6CF7-46DC-9A0D-1EF5BC1275C8Q28543176-DD74F332-560F-4B3A-BF0C-99E82289A036Q29615106-13A98D18-1C07-4624-92A0-CD071D979853Q30433397-E2031C7D-2F68-49F8-889B-3D2B77D171D8Q31115054-BAC2424A-E6F1-4F0D-AA86-55ADC31C091DQ33393451-38DC3899-ED4E-4C75-A921-E4CD8C7ACFB0Q33421740-5F72E5A8-F829-4AA4-A974-D34285509A67Q33604121-867558C1-FE9E-44F2-A247-C300F2E7CAEBQ33733534-4D4EBBAB-D040-4477-A51B-5696AE3BEC97Q33741498-A6EEB522-4A38-4749-A6A8-9EFBE95E648BQ33785788-FDE9C0ED-06E6-4FED-BC47-C2F150C79B9AQ33792003-9B3E91E8-43AE-4201-8697-A8C4C78FA222Q33798745-76E0A21B-EECF-4016-9B65-122F91829BD4Q33940675-E905B4A3-EAE9-4A0D-B68A-59A75A4A6CBCQ34120703-C5265BAF-DD6D-45B2-9AF7-2EA27A31FE04Q34180695-43CB8FF0-64D4-4B6A-983B-D60E5EAC1AB4Q34515512-55B8B15E-DABB-4CB9-A8E7-DB0F8D366988Q34551581-408885B9-010E-4C25-90A3-ABA4115B6CA7Q34700290-71F06F0F-21F7-444F-AD72-A245DCDE9EECQ34729280-3DC75A7B-875B-43C4-9946-6E3A86DA1DEEQ34985704-B8FDFB9B-37A6-4675-8A50-BAE80C6668D3Q34988727-CD5EBDFA-25EA-49BA-9161-E98E4DED64FAQ35002543-99E8D49B-B809-45CB-B4C2-D22547897CFCQ35181245-3E1E9E7F-E6EC-451A-948C-8D5EF11BACE5Q35201839-64290BE7-9296-4A5C-A1E0-A1088D2F2469Q35201881-26EDF8FF-72DC-4096-A6D3-5A1853437FC9Q35252186-B3481F25-8EC9-480B-9B38-EE8554CA0D83Q35269067-C75A743C-3460-457F-BC15-FB7250CEAE2BQ35553322-9B6C4B18-3629-4E27-9C72-081C330333BFQ35591444-B7046B2B-0545-43C8-8BA6-3F6D58C97CBBQ35600975-98ACAB93-C7B2-46CC-A9E9-4FBDFAD93C4AQ35677351-9A783F8B-1AE1-4E39-B6DC-72C3A94CA72DQ35752181-82F7FE06-AD6F-40A1-8391-84A9F70D3E7A
P2860
Natural killer cell-directed therapies: moving from unexpected results to successful strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Natural killer cell-directed t ...... ults to successful strategies.
@en
Natural killer cell-directed t ...... ults to successful strategies.
@nl
type
label
Natural killer cell-directed t ...... ults to successful strategies.
@en
Natural killer cell-directed t ...... ults to successful strategies.
@nl
prefLabel
Natural killer cell-directed t ...... ults to successful strategies.
@en
Natural killer cell-directed t ...... ults to successful strategies.
@nl
P50
P356
P1433
P1476
Natural killer cell-directed t ...... ults to successful strategies.
@en
P2093
Nicolas F Delahaye
P304
P356
10.1038/NI1580
P407
P577
2008-05-01T00:00:00Z